NCT05826158
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
- Locations
-
- Rigshospitalet, Copenhagen University Hospital Copenhagen, Denmark
Clinical trial condition
Neuroblastoma
Explore clinical trials studying Neuroblastoma. Study availability and eligibility vary by location and protocol.
355 public trials
67 recruiting studies
Neuroblastoma trial results
NCT06574698
- Conditions
- GD2 Antibody (Naxitamab), Neoplasms, Neoplasms by Histologic Type, +8 more
- Locations
-
- Guangzhou Women And Children's Medical Center Guanzhou, Guangdong, China
NCT06296732
- Conditions
- Ganglioneuroblastoma, Ganglioneuroma, Neoplasms, +9 more
- Locations
-
- Research Institute of Pediatric Hematology, Oncology and Immunology Moscow, Russia
NCT05069220
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +11 more
- Locations
-
- Peking union medical college hospital Beijing, Dongcheng, China
NCT04253015
- Conditions
- Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +14 more
- Locations
-
- St. Anna Kinderkrebsforschung Vienna, State of Vienna, Austria
- Centre Oscar Lambret Lille, France
- Hôpital de la Timone, Hôpital des Enfants Marseille, France
- Institut Curie Paris, France
NCT06071897
- Conditions
- Ganglioneuroblastoma, Neoplasms, Neoplasms by Histologic Type, +8 more
- Locations
-
- Research Institute of Pediatric Hematology, Oncology and Immunology Moscow, Russia
NCT01704716
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
- Locations
-
- Women and Children´s Hospital Adelaide, Australia
- Lady Cilento Children´s Hospital Brisbane, Australia
- John Hunter Children's Hospital Newcastle, Australia
- Royal Children's Hospital Melbourne Parkville, Australia
Not yet recruiting
4SCAR-T Therapy Targeting GD2, PSMA and CD276 for Treating Neuroblastoma
NCT04637503
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +24 more
- Locations
-
- Shenzhen Geno-Immune Medical Institute Shenzhen, Guangzhou, China
Not yet recruiting
NANT 2021-02: Randomized MIBG With Vorinostat/Dinutuximab/Vorinostat + Dinutuximab
NCT07261241
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
- Locations
-
- Children's Hospital Los Angeles Los Angeles, California, United States
- UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
- Children Hospital of Colorado Aurora, Colorado, United States
- Children's Healthcare of Atlanta Atlanta, Georgia, United States
Not yet recruiting
Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or Neuroblastoma
NCT07518654
- Conditions
- Hematologic Diseases, Hematopoetic Stem Cell Transplant, Hematopoetic Stem Cell Transplantation, +32 more
- Locations
-
- The Hospital for Sick Children Toronto, Ontario, Canada
- CHU Sainte-Justine Montreal, Quebec, Canada